1. Empagliflozin (BI 10773), a Potent and Selective SGLT2 Inhibitor, Induces Dose‐Dependent Glucosuria in Healthy Subjects. Issue 2 (27th March 2013) Authors: Seman, Leo; Macha, Sreeraj; Nehmiz, Gerhard; Simons, Gudrun; Ren, Bailuo; Pinnetti, Sabine; Woerle, Hans J.; Dugi, Klaus Journal: Clinical pharmacology in drug development Issue: Volume 2:Issue 2(2013:Apr.) Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LC–MS quantification of protein drugs: validating protein LC–MS methods with predigestion immunocapture. (September 2016) Authors: Duggan, Jeffrey; Ren, Bailuo; Mao, Yan; Chen, Lin-Zhi; Philip, Elsy Journal: Bioanalysis Issue: Volume 8:Number 18(2016) Page Start: 1951 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1‐061: Pharmacokinetics of Single and Multiple Rising Doses of BI 425809, A New Glyt1 Inhibitor, in Young and Elderly Healthy Volunteers. (1st July 2016) Authors: Moschetti, Viktoria; Schlecker, Christina; Schultz, Armin; Wind, Sven; Goetz, Sophia; Liesenfeld, Karl-Heinz; Schmitt, Holger; Mao, Yan; Ren, Bailuo; Wunderlich, Glen; Yum, Sun-Young A.; Desch, Michael Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 8 Page Start: P425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗